Skip to content

Douglas Kerr, Chief Medical Officer at Dyne Therapeutics, sold DYN on Sep 8, 2026

Data as of Oct 16

▼ SELL$24.4K1,290 shares at $18.88Douglas Kerr Chief Medical OfficerDYN Dyne Therapeutics, Inc.
Watch DYN
Traded
Sep 8, 2026
Disclosed
Sep 8, 2026
Filed
The same day

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Douglas Kerr, Chief Medical Officer at Dyne Therapeutics, sold DYN on Sep 8, 2026TRADEDDISCLOSED
DYNSimilar stocks (XLV — its sector index fund), rebased to DYN's price on the disclosure day
DYN since disclosure
−29.8%
after the sale
Similar stocks (XLV) since disclosure
+5.7%
XLV — its sector index fund

Change in closing price from Sep 8, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLDouglas Kerr Chief Medical OfficerDYN Dyne Therapeutics, Inc.$91.2Kdisclosed Sep 8 · filed 4 days after the trade

See every trade on DYN →